Danaher/$DHR
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Danaher
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Ticker
$DHR
Sector
Primary listing
NYSE
Industry
Life Sciences Tools & Services
Headquarters
Employees
62,000
ISIN
US2358511028
Website
Danaher Metrics
BasicAdvanced
$145B
39.27
$5.16
0.80
$1.13
0.63%
Price and volume
Market cap
$145B
Beta
0.8
52-week high
$281.70
52-week low
$171.00
Average daily volume
3.8M
Dividend rate
$1.13
Financial strength
Current ratio
1.433
Quick ratio
0.949
Long term debt to equity
33.576
Total debt to equity
34.562
Dividend payout ratio (TTM)
20.85%
Interest coverage (TTM)
17.92%
Profitability
EBITDA (TTM)
7,464
Gross margin (TTM)
59.80%
Net profit margin (TTM)
15.81%
Operating margin (TTM)
21.44%
Effective tax rate (TTM)
16.41%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
3.95%
Return on equity (TTM)
7.22%
Valuation
Price to earnings (TTM)
39.268
Price to revenue (TTM)
6.163
Price to book
2.85
Price to tangible book (TTM)
-14.95
Price to free cash flow (TTM)
29.946
Free cash flow yield (TTM)
3.34%
Free cash flow per share (TTM)
676.21%
Dividend yield (TTM)
0.56%
Forward dividend yield
0.63%
Growth
Revenue change (TTM)
0.35%
Earnings per share change (TTM)
-12.59%
3-year revenue growth (CAGR)
-7.69%
10-year revenue growth (CAGR)
2.19%
3-year earnings per share growth (CAGR)
-15.80%
10-year earnings per share growth (CAGR)
3.62%
3-year dividend per share growth (CAGR)
8.69%
10-year dividend per share growth (CAGR)
10.02%
What the Analysts think about Danaher
Analyst ratings (Buy, Hold, Sell) for Danaher stock.
Bulls say / Bears say
Barclays analyst Luke Sergott increased Danaher's price target to $215, citing effective management strategies to mitigate a potential $350 million tariff impact through pricing adjustments and supply chain actions. (investing.com)
Danaher reported first-quarter 2025 earnings exceeding expectations, with an adjusted EPS of $1.88 compared to the forecast of $1.62, and revenue of $5.74 billion against an anticipated $5.56 billion, indicating strong financial performance. (investing.com)
Stifel analyst Daniel Arias maintains a Buy rating with a price target of $260, highlighting strong customer demand in bioprocessing and the company's ability to offset tariff impacts, suggesting potential for growth. (benzinga.com)
Danaher's high valuation, with a P/E ratio of 36.4x, may limit upside potential and poses a risk if earnings growth does not meet investor expectations. (investing.com)
The company's third-quarter guidance fell below some investor expectations, indicating potential challenges in meeting future performance targets. (investing.com)
Danaher's exposure to potential industry-wide challenges or economic headwinds could impact its performance, especially given intense competition in the diagnostics and life sciences sectors. (investing.com)
Data summarised monthly by Lightyear AI. Last updated on 24 Jun 2025.
Danaher Financial Performance
Revenues and expenses
Danaher Earnings Performance
Company profitability
Danaher News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jul25
Danaher
Dividend·Payment
$0.32Per share
FAQs
What’s the current market cap for Danaher stock?
Danaher (DHR) has a market cap of $145B as of July 04, 2025.
What is the P/E ratio for Danaher stock?
The price to earnings (P/E) ratio for Danaher (DHR) stock is 39.27 as of July 04, 2025.
Does Danaher stock pay dividends?
Yes, the Danaher (DHR) stock pays dividends to shareholders. As of July 04, 2025, the dividend rate is $1.13 and the yield is 0.63%. Danaher has a payout ratio of 20.85% on a trailing twelve-month basis.
When is the next Danaher dividend payment date?
The next Danaher (DHR) dividend payment is scheduled for July 25, 2025.
What is the beta indicator for Danaher?
Danaher (DHR) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.